WIPRO Consumer Care and Lighting consolidates its presence in Foods with the acquisition of Brahmins

Wipro Consumer Care and Lighting consolidates its presence in Foods with the acquisition/buyout of Brahmins:Fabulous MASALA News announced in Namma BENGALURU

Bangalore, April 20, 2023

 Wipro Consumer Care and Lighting announced the execution of a definitive agreement to acquire Brahmins, a traditional vegetarian, spice mix and ready-to-cook(RTC) packaged food brand located/based in Kerala. Followed by its recent acquisition of Nirapara, the company is looking at becoming a sizable player in the packaged foods segment.

To expand and further consolidate its spices, breakfast and Ready to Cook category, WIPRO has taken the route towards adding Brahmins, a homegrown legacy brand in Kerala, into its growing Food Business. Established in 1987, Brahmins is one of the most preferred brands in its home market (Kerala), with ethnic breakfast pre-mix powders, spice mixes, straight powders (spices), wheat products such as - pickles, dessert mixes, and others. The premium flagship products are Sambar Powder, and Puttu Podi which enjoy market leadership position. 

Commenting on the acquisition, Vineet Agrawal, CEO of WIPRO Consumer Care and Lighting and Managing Director, WIPRO Enterprises said, “We entered the Food category with our first acquisition of Nirapara and within six months, we are happy to share our latest acquisition of Brahmins. 

                                             

In Kerala, Brahmins is a strong heritage brand leading the spice and ready- to-cook(RTC) category with a significant consumer recall. I am particularly impressed by the highly competent and dedicated team. The high-quality standards adopted by Brahmins have played a key role in making it one of the most significant players in the market. We intend to make this, our 14th acquisition, as successful as our previous ones”. Sreenath Vishnu, MD, Brahmins said, “I am elated that Brahmins is now a part of WIPRO Consumer Care Foods Business.

                                              

Brahmins Food Products Launch in Namma BENGALURU

 This will enable access to resources that will help the brand grow rapidly. We are jointly focused on developing the brand supported by local consumer insights as well as streamlining manufacturing. We are confident that with WIPRO’s distribution strength, network, and marketing expertise we will significantly expand our geographical presence and scale Brahmins to newer heights.” 

Anil Chugh, President, Foods Business, WIPRO Consumer Care commented on the acquisition stating, “This is an exciting time for us at WIPRO, as we witness the unprecedented expansion of our Foods Business. Spices and Ready-to-cook (RTC) are big categories that are poised to grow significantly. Adding Brahmins under the Wipro fold will further bolster our position in blended spices and ethnic breakfast (Puttu-podi, Appams and other Rice products) categories in Kerala and other markets such as the GCC countries, UK, US & Australia.

About Brahmins(the Company/ Brand,not the Caste/People ! ):

 Established in 1987 by Mr. Vishnu Namboothiri in the Southern Indian State of KERALA [ God's own Country ], the family-owned Brahmins offers a range of packaged breakfast and spice mix products which are strictly based on the concept of vegetarianism. The Company offers 100+ SKUs across Kerala, metro cities in rest of India, and in overseas markets including the GCC Countries, the USA, the UK, and Australia. Brahmins is one of the most preferred brands in its home market [Kerala],other Southern States like Namma Karnataka,Tamil Nadu,Andhra Pradesh..) and other parts of the country. 

Brahmins products offer a 100 % VEGETARIAN PROMISE of PURITY with the Highest Standards of Quality Assurance/Quality Control,are reasonably priced and sure will  appeal to BRAHMINS/GASTRONOMES/Vegetarians..and other people with discerning Tastes/Palates.

For more info/details,pleae visit/peruse:

https://www.wiproconsumercare.com 

https://www.brahminsfoods.com

https://www.brahminsgroup.com

LUPIN DIAGNOSTICS Launches Regional Reference Laboratory in Namma BENGALURU, Strengthening Presence in South India

Lupin Limited announced today the launch of its new state-of-the-art Regional Reference Laboratory in Namma BENGALURU, Karnataka, as part of the expansion of its diagnostics network.

 

The Regional Reference Laboratory complements the company's existing network of 25 laboratories and 410+ collection centers across India.

After establishing presence in Hyderabad, this launch expands footprint in South India

 

Bengaluru, India, April 12, 2023: Global pharma major Lupin Limited (Lupin) announced today the launch of its new state-of-the-art Regional Reference Laboratory in Bengaluru, Karnataka, as part of the expansion of its diagnostics network. The new laboratory marks a significant step forward in Lupin Diagnostics' mission to provide accessible and affordable diagnostics and preventive healthcare services across India. The Regional Reference Laboratory complements the company's existing network of 25 laboratories and 410+ collection centers across India.

 

The new laboratory in Bengaluru is equipped with cutting-edge technologies and staffed by highly qualified clinical experts, enabling Lupin Diagnostics to deliver high-quality and reliable diagnostic services to patients and consumers across Bengaluru and neighboring cities.

 

In addition to routine and specialized tests, the laboratory offers a comprehensive range of diagnostics services, including molecular diagnostics, cytogenetics, flow cytometry, cytology, microbiology, serology, haematology, histopathology, immunology, routine biochemistry, among others. Lupin Diagnostics leverages state-of-the-art automation and streamlined processes to deliver highly accurate test results, empowering patients to make informed decisions about their health.

 

“Ensuring that quality diagnostics are accessible and affordable for everyone in India is at the core of our mission,” said Mr.Ravindra Kumar, CEO of Lupin Diagnostics(seen in photo below,LHS)

                                   

                                    

 “Accurate diagnosis is crucial for effective disease management, and we are committed to providing our patients with reliable, high-quality diagnostic services. With our cutting-edge technology and personalized smart reports, patients and doctors can gain valuable insights into health trends and make informed decisions about treatment options,” he added.

 

Lupin Diagnostics provides an unparalleled range of diagnostic services to doctors, patients, and consumers. As a testament to the company’s unwavering commitment to quality and accuracy, 2 of its laboratories have already achieved NABL accreditation. This milestone reinforces Lupin Diagnostics’ position as a trusted leader in the healthcare industry and prioritizes excellence in everything it does.

 

About Lupin

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

 

The Company enjoys a leadership position in the cardiovascular, anti-diabetic, and respiratory segments and has a significant presence in the anti-infective, gastrointestinal (GI), central nervous system (CNS), and women’s health areas. Lupin is the third-largest pharmaceutical company in the U.S. by prescriptions. The company invested 8.7% of its revenue in research and development in FY22.

Lupin has 15 manufacturing sites, 7 research centres, more than 20,000 professionals working globally, and has been consistently recognized as a 'Great Place to Work' in the Biotechnology & Pharmaceuticals sector.

Please visit www.lupin.com for more information.

 

About Lupin Diagnostics

Lupin Diagnostics Limited is a wholly owned subsidiary of Lupin Limited. Founded in December 2021, the company is headquartered in Mumbai, India and provides comprehensive range of diagnostic services to doctors, patients, and consumers.

 

The company began its journey by establishing a state-of-the-art 45,000 sq. ft. National Reference Laboratory located in Navi Mumbai with world-class equipment, experienced doctors assisted by trained technologists and stringent quality control protocols. Over 2,500 tests including routine and high-end tests are offered under Pathology (molecular diagnostics, cytology, microbiology, serology, hematology, histopathology, immunology, and routine biochemistry).

 

Currently, the company’s network consists of 25 Labs, 410+ exclusive collection centers (LupiMitra), and over 1200 pick-up points.

 

Please visit/peruse/Experience the best diagnostic experiences with Lupin Diagnostics - https://www.lupindiagnostics.com/